Global gene expression analysis in cord blood reveals gender-specific differences in response to carcinogenic exposure in Utero

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 10, 2012, Pages 1756-1767

  Hochstenbach, Kevin ^a   Van Leeuwen, Danitsja M ^a   Gmuender, Hans ^d   Gottschalk, Ralf W ^a   Løvik, Martinus ^e   Granum, Berit ^e   Nygaard, Unni ^e   Namork, Ellen ^e   Kirsch Volders, Micheline ^f   Decordier, Ilse ^f   Loock, Kim Vande ^e   Besselink, Harrie ^b   Törnqvist, Margareta ^g   Von Stedingk, Hans ^g   Rydberg, Per ^g   Kleinjans, Jos C S ^a   Van Loveren, Henk ^a,c   Van Delft, Joost H M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b BIODETECTION SYSTEMS B V   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d GENEDATA AG   (Switzerland)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^f FREE UNIVERSITY OF BRUSSELS   (Belgium)

^g STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CARCINOGEN; CD79B ANTIGEN; DIOXIN; ESTROGEN RECEPTOR ALPHA; EWING SARCOMA BREAKPOINT REGION 1; HEAT SHOCK PROTEIN 90; HEMOGLOBIN; IMMUNOGLOBULIN HEAVY CHAIN; JANUS KINASE 2; K RAS PROTEIN; PROTEIN BCL 2; PROTEIN KINASE LCK; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR RUNX1; TROPOMYOSIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 384;

ARTICLE; BLOOD SAMPLING; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CYCLE; CHILDHOOD CANCER; CYTOKINESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MICRONUCLEUS; NEWBORN; PHENOTYPE; PRENATAL EXPOSURE; PRIORITY JOURNAL; SEX DIFFERENCE; UMBILICAL CORD BLOOD;

ACRYLAMIDE; ADULT; BIOLOGICAL MARKERS; CARCINOGENS; ESTROGEN RECEPTOR ALPHA; FEMALE; FETAL BLOOD; FETUS; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; PREGNANCY; RECEPTORS, ANDROGEN; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 84867291614     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0304     Document Type: Article

References (53)

1. Cartwright RA, Gurney KA, Moorman AV. Sex ratios and the risks of haematological malignancies. Br J Haematol 2002;118:1071-7. (Pubitemid 35025971)
2. Linet MS, Wacholder S, Zahm SH. Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics 2003;112:218-32. (Pubitemid 36792916)
3. Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Res 1990;50:7415-21.
4. Tower RL, Spector LG. The epidemiology of childhood leukemia with a focus on birth weight and diet. Crit Rev Clin Lab Sci 2007;44:203-42. (Pubitemid 46525177)
5. Pombo-de-Oliveira MS, Koifman S. Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 2006;15:2336-41. (Pubitemid 46048287)
6. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004;364:2097-105. (Pubitemid 39626805)
7. Wild CP, Kleinjans J. Children and increased susceptibility to environmental carcinogens: evidence or empathy? Cancer Epidemiol Biomarkers Prev 2003;12:1389-94. (Pubitemid 38031739)
8. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Eng J Med 2008:359:61-73.
9. Mose T, Mathiesen L, Karttunen V, Nielsen JK, Sieppi E, Kummu M, et al. Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta 2012;33:433-9.
10. Annola K, Keski-Rahkonen P, Vahakangas K, Lehtonen M. Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography- electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2008;876:191-7.
11. Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 2010;202:e1-7.
12. Sala M, Ribas-Fitó N, Cardo E, de Muga ME, Marco E, Mazón C, et al. Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta. Chemosphere 2001;43:895-901.
13. Wang SL, Lin CY, Guo YL, Lin LY, Chou WL, Chang LW. Infant exposure to polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls (PCDD/Fs, PCBs)-correlation between prenatal and postnatal exposure. Chemosphere 2004;54:1459-73. (Pubitemid 38147873)
14. Gizzi G, Vincent U, von Holst C, de Jong J, Genouel C. Validation of an analytical method for the determination of carbadox and olaquindox in feedstuff by liquid chromatography coupled to UV and/or diode array detection. Food Addit Contam 2007;24:1226-35. (Pubitemid 47559900)
15. Choi SM, Yoo SD, Lee BM. Toxicological characteristics of endocrine-disrupting chemicals: developmental toxicity, carcinogenicity, and mutagenicity. J Toxicol Environ Health B Crit Rev 2004;7:1-24. (Pubitemid 38117512)
16. Tareke E, Rydberg P, Karlsson P, Eriksson S, Tornqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002;50:4998-5006. (Pubitemid 34856181)
17. Tornqvist M. Acrylamide in food: the discovery and its implications: a historical perspective. Adv Exp Med Biol 2005;561:1-19. (Pubitemid 43779445)
18. Ghanayem BI, Witt KL, Kissling GE, Tice RR, Recio L. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat Res 2005;578:284-97. (Pubitemid 41395332)
19. Besaratinia A, Pfeifer GP. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 2007;28:519-28. (Pubitemid 46523347)
20. von Stedingk H, Rydberg P, Tornqvist M. A new modified Edman procedure for analysis of N-terminal valine adducts in hemoglobin by LC-MS/MS. J ChromatogrBAnalyt Technol Biomed Life Sci 2010;878:2483-90.
21. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2007;2:1084-104. (Pubitemid 46901289)
22. Kirsch-Volders M, Elhajouji A, Cundari E, Van Hummelen P. The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat Res 1997;392:19-30. (Pubitemid 27327005)
23. Kirsch-Volders M, Plas G, Elhajouji A, Lukamowicz M, Gonzalez L, Vande Loock K, et al. The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch Toxicol 2011;85:873-99.
24. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 2007;28:625-31. (Pubitemid 46523357)
25. Brouwers MM, Besselink H, Bretveld RW, Anzion R, Scheepers PT, Brouwer A, et al. Estrogenic and androgenic activities in total plasma measured with reporter-gene bioassays: relevant exposure measures for endocrine disruptors in epidemiologic studies? Environ Int 2011;37:557-64.
26. Pedersen M, Halldorsson TI, Mathiesen L, Mose T, Brouwer A, Hedegaard M, et al. Dioxin-like exposures and effects on estrogenic and androgenic exposures and micronuclei frequency in mother-newborn pairs. Environ Int 2010;36:344-51.
27. von Stedingk H, Vikstr̈om AC, Rydberg P, Pedersen M, Nielsen JK, Segerb̈ack D, et al. Analysis of hemoglobin adducts from acrylamide, glycidamide, and ethylene oxide in paired mother/cord blood samples from Denmark. Chem Res Toxicol 2011;24:1957-65.
28. Decordier I, Papine A, Plas G, Roesems S, Vande Loock K, Moreno-Palomo J, et al. Automated image analysis of cytokinesis-blocked micronuclei: an adapted protocol and a validated scoring procedure for biomonitoring. Mutagenesis 2009;24(1):85-93.
29. Vande Loock K, Fthenou E, Decordier I, Chalkiadaki G, Keramarou M, Plas G, et al. Maternal and gestational factors and micronuclei frequencies in umbilical blood: the NewGeneris Rhea Cohort in Crete. Environ Health Perspect 2011;119:1460-5.
30. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-10. (Pubitemid 34679544)
31. Available at: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31836.
32. Boorsma A, Foat BC, Vis D, Klis F, Bussemaker HJ. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res 2005;33:W592-5. (Pubitemid 44529991)
33. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83. (Pubitemid 38337497)
34. Morgan JE, Whitlock JP Jr. Transcription-dependent and transcription-independent nucleosome disruption induced by dioxin. Proc Natl Acad Sci U S A 1992;89:11622-6.
35. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009;77:713-22.
36. Yoshizawa K, Heatherly A, Malarkey DE, Walker NJ, Nyska A. A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF. Toxicol Pathol 2007;35:865-79.
37. Pieters R. Biology and treatment of infant leukemias. In:Pui ChinHon, editor. Treatment of acute leukemias. New directions for Clinical Research. Totowa. Humana Press; 2003: p. 61-75.
38. Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med 2010;42:161-70.
39. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009;9:361-71.
40. Jost PJ, Ruland J. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. Blood 2007;109:2700-7. (Pubitemid 46482061)
41. Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia 2000;14:399-402. (Pubitemid 30142862)
42. Do TN, Ucisik-Akkaya E, Davis CF, Morrison BA, Dorak MT. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males. Biochim Biophys Acta 2010;1802:292-300.
43. Kast RE, Altschuler EL. Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha. Arch Immunol Ther Exp (Warsz) 2005;53:143-7. (Pubitemid 41057864)
44. Mullighan CG, Zhang J, Harvey RC, Collins-Underwood Jr, Schulman BA, Phillips LA, et al. JAK mutations in high-risk childhood acute lymphoblastic ##leukemia. Proc Natl Acad Sci U S A 2009;106:9414-8.
45. Benetatos L, Dasoula A, Syed N, Hatzimichael E, Crook T, Bourantas KL. Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes. Leukemia 2008;22:1293-5. (Pubitemid 351833811)
46. Pierdominici M, Maselli A, Colasanti T, Giammarioli AM, Delunardo F, Vacirca D, et al. Estrogen receptor profiles in human peripheral blood lymphocytes. Immunol Lett 2010;132:79-85.
47. Ramsay AG, Gribben JG. Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug. Haematologica 2009;94:1198-202.
48. Ansari KI, Mishra BP, Mandal SS. MLL histone methylases in gene expression, hormone signaling and cell cycle. Front Biosci 2009;14:3483-95.
49. Ross JA, Robison LL.MLLrearrangements in infant leukemia: is there a higher frequency in females? Leuk Res 1997;21:793-5. (Pubitemid 27458633)
50. Heisler LE, Evangelou A, Lew AM, Trachtenberg J, Elsholtz HP, Brown TJ. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 1997;126:59-73. (Pubitemid 27055548)
51. Holland N, Fucic A, Merlo DF, Sram R, Kirsch-Volders M. Micronuclei in neonates and children: effects of environmental, genetic, demographic and disease variables. Mutagenesis 2011;26:51-6.
52. Milosevic-Djordjevic O, Grujicic D, Arsenijevic S, Brkic M, Ugrinovic S, Marinkovic D. Micronuclei in cord blood lymphocytes as a biomarker of transplacental exposure to environmental pollutants. Tohoku J Exp Med 2007;213:231-9. (Pubitemid 350258295)
53. van Leeuwen DM, Pedersen M, Knudsen LE, Bonassi S, Fenech M, Kleinjans JC, et al. Transcriptomic network analysis of micronuclei-related genes: a case study. Mutagenesis 2011;26:27-32.